Rich Gaspari has been involved in the bodybuilding and fitness field for more than 30 years
10.1172/JCI72434 261
By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity
Check Your Hydration The brain often confuses thirst signals for hunger signals
What sets them apart is their objective, data driven approach to health to measure the impact of your efforts, and of course, access to health coaching. Sharon Curtain Dietitian and Director, Accredited Health Coaching Australia I wholeheartedly endorse MFM as a trusted partner in the quest for optimal health and vitality
Improved Energy Levels: With continued metabolic adjustment and the benefits of weight loss, many individuals report feeling more energetic